| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| parp inhibitor resistance | 0.49 | 0.2 | 3625 | 66 | 25 |
| parp | 0.86 | 0.7 | 7079 | 90 | 4 |
| inhibitor | 0.11 | 0.6 | 1092 | 2 | 9 |
| resistance | 1.43 | 0.3 | 4492 | 28 | 10 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| parp inhibitor resistance | 0.84 | 0.2 | 8764 | 98 |
| parp inhibitor resistance ovarian cancer | 0.35 | 0.4 | 4754 | 86 |
| parp inhibitor resistance mechanisms | 1.86 | 1 | 7088 | 16 |
| tackling parp inhibitor resistance | 0.94 | 0.8 | 8629 | 4 |
| mechanism of parp inhibitor resistance | 1.99 | 1 | 9118 | 17 |
| parp inhibitor for ovarian cancer maintenance | 0.91 | 0.6 | 464 | 99 |
| ovarian cancer parp inhibitor | 1.25 | 0.1 | 3804 | 56 |
| parp inhibitors in ovarian cancer | 0.46 | 0.2 | 5261 | 34 |
| parp inhibitor drugs ovarian cancer | 1.83 | 0.2 | 2447 | 15 |
| role of parp inhibitors in ovarian cancer | 1.03 | 0.5 | 7756 | 95 |
| parp inhibitor ovarian cancer 2020 | 1.12 | 0.5 | 6945 | 26 |
| fda approval parp inhibitor ovarian cancer | 0.82 | 0.5 | 2517 | 85 |
| parp for ovarian cancer | 0.37 | 0.2 | 9660 | 47 |
| parp inhibitor breast cancer | 0.99 | 0.2 | 157 | 41 |
